ABI Says SOLiD Found More Forms of Variation in HapMap than Illumina; No Formal Comparison Yet | GenomeWeb

By Julia Karow

Applied Biosystems' SOLiD platform discovered more forms of genome variation in a HapMap sample with less coverage than Illumina's Genome Analyzer did in a previous analysis of the same sample, although the overall number of variations discovered was smaller, according to an ABI researcher. However, a formal comparison of the two studies — which both used sequencing platforms that have since improved — has not been published to date.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

After nine years, the Canadian government is loosening its restrictions on government scientists' ability to speak to the press and public.

In PNAS this week: genetic method to gauge age of ancient samples, genetic polymorphisms in mouse strain, and more.

Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.